Tags

Type your tag names separated by a space and hit enter

Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
Ann Hematol. 2020 Jul; 99(7):1675-1676.AH

Authors+Show Affiliations

Ematologia e CTMO, Ospedale Businco Azienda Ospedaliera Brotzu, Dipartimento di Scienze Mediche e Sanità Pubblica, Università di Cagliari, Via Jenner, sn, 09124, Cagliari, Italy. giovanni.caocci@unica.it.Ematologia e CTMO, Ospedale Businco Azienda Ospedaliera Brotzu, Dipartimento di Scienze Mediche e Sanità Pubblica, Università di Cagliari, Via Jenner, sn, 09124, Cagliari, Italy.

Pub Type(s)

Letter

Language

eng

PubMed ID

32405693

Citation

Caocci, Giovanni, and Giorgio La Nasa. "Could Ruxolitinib Be Effective in Patients With COVID-19 Infection at Risk of Acute Respiratory Distress Syndrome (ARDS)?" Annals of Hematology, vol. 99, no. 7, 2020, pp. 1675-1676.
Caocci G, La Nasa G. Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)? Ann Hematol. 2020;99(7):1675-1676.
Caocci, G., & La Nasa, G. (2020). Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)? Annals of Hematology, 99(7), 1675-1676. https://doi.org/10.1007/s00277-020-04067-6
Caocci G, La Nasa G. Could Ruxolitinib Be Effective in Patients With COVID-19 Infection at Risk of Acute Respiratory Distress Syndrome (ARDS). Ann Hematol. 2020;99(7):1675-1676. PubMed PMID: 32405693.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)? AU - Caocci,Giovanni, AU - La Nasa,Giorgio, Y1 - 2020/05/14/ PY - 2020/03/31/received PY - 2020/04/27/accepted PY - 2020/5/15/pubmed PY - 2020/7/15/medline PY - 2020/5/15/entrez SP - 1675 EP - 1676 JF - Annals of hematology JO - Ann Hematol VL - 99 IS - 7 SN - 1432-0584 UR - https://www.unboundmedicine.com/medline/citation/32405693/Could_ruxolitinib_be_effective_in_patients_with_COVID_19_infection_at_risk_of_acute_respiratory_distress_syndrome__ARDS_ L2 - https://dx.doi.org/10.1007/s00277-020-04067-6 DB - PRIME DP - Unbound Medicine ER -